2024. Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Annals of Gastroenterology and Digestive Disorders. 7, 1 (Jul. 2024), 32–6. DOI:https://doi.org/10.5281/zenodo.22179529.